News | November 07, 2023
Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023
Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023
Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
This product will be manufactured at Lupin's Nagpur facility in India
Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
Subscribe To Our Newsletter & Stay Updated
